HOME >> BIOLOGY >> NEWS
Independent panel to evaluate genistein or soy formula human development, reproduction risks

What: An independent panel of 14 scientists convened by the Center for the Evaluation of Risks to Human Reproduction (CERHR), of the NIEHS and National Toxicology Program, will review recent scientific data and reach conclusions regarding whether or not exposure to genistein or soy formula is hazardous to human development or reproduction. The 2.5 day meeting is open to members of the public and the media. A press availability period will immediately follow the meeting at approximately noon on Friday, March 17.

When: Wednesday, March 15, 2006, 8:30 a.m. 5:00 p.m.
Thursday, March 16, 2006, 8:30 a.m. 5:00 p.m.
Friday, March 17, 2006, 8:30 a.m. noon
Press Availability: Friday, March 17, 2006 approximately 12-1p.m.

Where: Jefferson Ballroom
Radisson Hotel Old Town
901 N. Fairfax Street,
Alexandria VA 22314-1501, USA
Tel: (703) 683-6000
Fax: (703) 683-7597
http://www.radisson.com/alexandriava

Why: Exposure to genistein continues to rise in the United States with estimated soy sales in 2003 approaching $4 billion. A form of genistein is a primary, naturally occurring estrogen in soybeans (estrogenic chemicals in plants are called phytoestrogens) and can mimic the effects of estrogen in the body. Genistein can be found in foods containing soy such as soy-based infant formulas, tofu, soy milk, soy flour, textured soy protein, tempeh, and miso, as well as over-the-counter dietary supplements. Soy-infant formulas are widely used. It is estimated that 10-20 percent of infants in the United States are fed soy formula. It is often administered to infants as a supplement or replacement for maternal breast milk or cow's milk.

Soy products are often promoted as a natural, safe way to achieve at least some of the benefits of hormone replacement therapy in adults, but there is growing public concern about the long-term effect
'"/>

Contact: Robin Mackar
rmackar@niehs.nih.gov
919-541-0073
NIH/National Institute of Environmental Health Sciences
8-Mar-2006


Page: 1 2 3

Related biology news :

1. Independent panel to evaluate widely used chemical, Bisphenol A
2. Independent researchers confirm the existence of ivory-billed woodpecker
3. Not so contoversial anymore -- panel says moderate coffee drinking reduces many risks
4. National panel led by LSU Chancellor releases report on Corps of Engineers
5. NSAIDs modulate biomarker panel for esophageal adenocarcinoma
6. AAAS panel will focus on the impact of livestock production on the planet
7. NIH panel urges more informed approach to multivitamin/mineral use for chronic disease prevention
8. PITT research integrity panel finds that Dr. Gerald Schatten committed no scientific misconduct
9. Institute for OneWorld Health hosts panels at ASTMH
10. 9/11 panel makes recommendations for DNA-based identification after mass disasters
11. Pall tells FDA panel about blood filtering technology

Post Your Comments:
(Date:6/18/2013)... Faculty of Medicine have discovered a mechanism that is ... a component of blood typically associated with clotting, were ... detection, seal it off from the rest of the ... Immunology this week, provide the science community with ... has known that platelets do participate in immunity, but ...
(Date:6/18/2013)... United Kingdom, the Energy Department,s National Renewable Energy ... recently published a paper describing a novel cellulose-degrading ... quadripunctata , commonly known as the gribble. ... a relatively unique ability to produce their own ... down the biomass they eat. New biomass-degrading enzymes ...
(Date:6/18/2013)... A UT Arlington environmental engineer has been awarded ... District to ensure water quality and flow in ... Project. , Andrew Kruzic, UT Arlington associate professor ... and locations to add monochloramine to the water ... the new pump stations and pipelines. Adding monochloramine ...
Breaking Biology News(10 mins):Immunity mechanism discovered 2Novel enzyme from tiny gribble could prove a boon for biofuels research 2UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2
(Date:6/18/2013)... June 18, 2013  AMRI (NASDAQ: ... Burlington, Mass. , site has received approval ... (DEA) registration to handle Schedule 2 and 2N ... of Burlington,s physical security ... (Logo: http://photos.prnewswire.com/prnh/20120229/NY61160LOGO ) ...
(Date:6/18/2013)... ZIONA, Israel , June 18, 2013 /PRNewswire/ ... bulk Active Pharmaceutical Ingredients (APIs), generic and innovative intermediates, and ... today that the company has been granted a ... in the US and Europe for ... Patent number 8,410,176 B2 is titled Intermediate Compounds and ...
(Date:6/18/2013)... This webinar will examine the history ... and review the basic FDA regulations and guiding ... these principles through real world case studies and ... on FDA regulations and guidance related to prescription ... traditional and newer forms of promotional materials for ...
(Date:6/18/2013)... , June 18, 2013 ... ) has announced the addition of the ... [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & ... & Auto Injectors] & Therapeutics [Diabetes & ... report to their offering.      ...
Breaking Biology Technology:AMRI Burlington Receives DEA Approval to Handle Controlled Substances 2Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2Drug Advertising and Promotion Labeling: FDA Regulations, New Webinar Hosted by Xtalks 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 3
Cached News: